In addition, increased systemic levels of the endothelial growth factors VEGF, FGF2, and hepatocyte growth factor (HGF) directly correlated with increased bone marrow vascularization in MDS, AML, and MPN[76,77,79,81]. This evidence concerns the gene HGF and myeloproliferative disorder.